Goodbody Health Inc (AQSE:GDBY, CSE:GDBY, OTCQB:GDBYF) said it is launching new genetic tests to help people understand their risk of cancer and heart disease.
It will do so in conjunction with Everything Genetic, the testing services specialist, to provide four different products.
The polygenetic tests add to the existing portfolio to help customers ‘know more, live better’, Goodbody said.
"We are very excited about the launch of these new genetic tests which enhance our range of diagnostic tests,” said chairman Geremy Thomas.
“With the current pressures on the NHS we are pleased to be playing a part in helping customers to help themselves. There has never been a better time to take control of your current health."
For more information, click here.